BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30406099)

  • 1. Defining Skin Fibroblastic Cell Types Beyond CD90.
    Jiang D; Rinkevich Y
    Front Cell Dev Biol; 2018; 6():133. PubMed ID: 30406099
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensive CD34-to-CD90 Fibroblast Transition Defines Regions of Cutaneous Reparative, Hypertrophic, and Keloidal Scarring.
    Ho JD; Chung HJ; Ms Barron A; Ho DA; Sahni D; Browning JL; Bhawan J
    Am J Dermatopathol; 2019 Jan; 41(1):16-28. PubMed ID: 30320623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple roles of CD90 in cancer.
    Kumar A; Bhanja A; Bhattacharyya J; Jaganathan BG
    Tumour Biol; 2016 Sep; 37(9):11611-11622. PubMed ID: 27337957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD90 and CD105 expression in the mouse ovary and testis at different stages of postnatal development.
    Tepekoy F; Ozturk S; Sozen B; Ozay RS; Akkoyunlu G; Demir N
    Reprod Biol; 2015 Dec; 15(4):195-204. PubMed ID: 26679159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editor's Highlight: Thy1 (CD90) Expression is Reduced by the Environmental Chemical Tetrabromobisphenol-A to Promote Adipogenesis Through Induction of microRNA-103.
    Woeller CF; Flores E; Pollock SJ; Phipps RP
    Toxicol Sci; 2017 Jun; 157(2):305-319. PubMed ID: 28329833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD90
    Chang Y; Li C; Jia Y; Chen P; Guo Y; Li A; Guo Z
    Int J Biochem Cell Biol; 2018 Mar; 96():20-28. PubMed ID: 29339198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis.
    Lu JW; Chang JG; Yeh KT; Chen RM; Tsai JJ; Hu RM
    Acta Histochem; 2011 Dec; 113(8):833-8. PubMed ID: 21272924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.
    Woeller CF; O'Loughlin CW; Pollock SJ; Thatcher TH; Feldon SE; Phipps RP
    FASEB J; 2015 Mar; 29(3):920-31. PubMed ID: 25416548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Silencing of
    Montanari M; Carbone MR; Coppola L; Giuliano M; Arpino G; Lauria R; Nardone A; Leccia F; Trivedi MV; Garbi C; Bianco R; Avvedimento EV; De Placido S; Veneziani BM
    Mol Cancer Res; 2019 Feb; 17(2):628-641. PubMed ID: 30242055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Study of Lipofibroblasts Differentiation of CD90⁺ and CD90⁻ Orbital Fibroblasts Subsets in Patients with TAO].
    Gan L; Luo QL; Tang F; Wu WW; Tang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May; 47(3):356-9. PubMed ID: 27468480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thy1 (+) and (-) lung fibrosis subpopulations in LEW and F344 rats.
    McIntosh JC; Hagood JS; Richardson TL; Simecka JW
    Eur Respir J; 1994 Dec; 7(12):2131-8. PubMed ID: 7536165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem Cell Markers Describe a Transition From Somatic to Pluripotent Cell States in a Rat Model of Endometriosis.
    Othman ER; Meligy FY; Sayed AA; El-Mokhtar MA; Refaiy AM
    Reprod Sci; 2018 Jun; 25(6):873-881. PubMed ID: 28325116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells.
    Zhang K; Che S; Su Z; Zheng S; Zhang H; Yang S; Li W; Liu J
    Int J Mol Med; 2018 Feb; 41(2):946-954. PubMed ID: 29251325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD90 a potential cancer stem cell marker and a therapeutic target.
    Shaikh MV; Kala M; Nivsarkar M
    Cancer Biomark; 2016; 16(3):301-7. PubMed ID: 27062695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer.
    Shi J; Lu P; Shen W; He R; Yang MW; Fang Y; Sun YW; Niu N; Xue J
    Cancer Lett; 2019 Jul; 453():158-169. PubMed ID: 30954649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Thy1/CD90 Surface Glycoprotein: Sensor of Microenvironment?
    Felley-Bosco E; Leyton L
    Front Cell Dev Biol; 2019; 7():162. PubMed ID: 31457010
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
    Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.
    Nazari B; Rice LM; Stifano G; Barron AM; Wang YM; Korndorf T; Lee J; Bhawan J; Lafyatis R; Browning JL
    Am J Pathol; 2016 Oct; 186(10):2650-64. PubMed ID: 27565038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of fibroblast-like cells from the rat olfactory bulb.
    Soleimani M; Nadri S; Salehi M; Sobhani A; Hajarizadeh A
    Int J Dev Biol; 2008; 52(7):979-84. PubMed ID: 18956328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thy1 is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice.
    Paine A; Woeller CF; Zhang H; de la Luz Garcia-Hernandez M; Huertas N; Xing L; Phipps RP; Ritchlin CT
    FASEB J; 2018 Jun; 32(6):3174-3183. PubMed ID: 29401595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.